APR 21, 2021 8:00 AM PDT

Human T Cells Can't Recognize COVID Mutants

WRITTEN BY: Tara Fernandez

Genetic variants of the SARS-CoV-2 virus have emerged and tightened their grip on global communities as the pandemic rages on. In the United States, variants such as B.1.1.7, B.1.351, and P.1have been classified by the CDC as “variants of concern”—flagged for their ability to cause more severe disease and undercut the effectiveness of vaccines, treatments, and diagnostics.

Now, a recent study has revealed how these mutants are also able to evade recognition by T cells. 

Virally-infected cells use class 1 major histocompatibility complex proteins (or MHCs) to display fragments of viral peptides on the cell surface. Immune T cells circulate the body on the hunt for pathogenic intruders. When they recognize a suspicious-looking peptide bound to an MHC molecule, the T cell is activated, releasing cytotoxic factors to destroy the infected cell and restrict the pathogen’s ability to do more damage.

However, viruses are adaptable and have ways of avoiding T cell detection, such as by blocking MHC molecules bearing viral peptides from getting to the cell surface.

The research team studied how SARS-CoV-2 mutations affected T cell recognition compared to the wild-type virus. "We found that several variants resulted in complete loss of responsiveness to the T cell lines evaluated," wrote the authors of the study, uploaded to the preprint server bioRxiv.

The scientists hypothesize a number of mechanisms by which the mutants are resisting elimination by T cells including potential differences in antigen-presenting or the mutants’ ability to interfere with the recognition of the MHC-bound peptide by the T cell receptor.

To confirm these findings, the team exposed viral peptides from variants to T cells isolated from convalescent donors. They found that these T cells showed markedly decreased functionality when it came to recognizing viral peptides as pathogenic.

"Our findings demonstrate the potential for T-cell evasion and highlight the need for ongoing surveillance for variants capable of escaping T-cell as well as humoral immunity," wrote the authors.

 



Source: BioRxiv.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 07, 2021
Health & Medicine
Think you can pay back your sleep debt this weekend? Think again.
SEP 07, 2021
Think you can pay back your sleep debt this weekend? Think again.
Researchers find that even one night of sleep loss results in impaired functioning and well being.
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
OCT 19, 2021
Cell & Molecular Biology
Mouse Fathers Passed Immunity Onto Offpsring After Infection
OCT 19, 2021
Mouse Fathers Passed Immunity Onto Offpsring After Infection
Parents pass their genes on to their children. But they can pass down other things too with epigenetic marks, chemical t ...
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
OCT 28, 2021
Cancer
NF-κB: a Trick or a Treat for Cancer?
OCT 28, 2021
NF-κB: a Trick or a Treat for Cancer?
A family of proteins, known as transcription factors, regulate the biological process of converting DNA into RNA. T ...
DEC 02, 2021
Cancer
A New Method to Enhance Immunotherapy in Mouse Tumors
DEC 02, 2021
A New Method to Enhance Immunotherapy in Mouse Tumors
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, accounting for about 90% of pancre ...
Loading Comments...